This month we interview Zhuoheng Zhou from the Vrije Universiteit Brussel in Belgium, about his focus on advancing instrumental and column technologies for modern chromatography and its applications in novel biopharmaceutical modalities and proteomics. We also spoke to him about his work developing a protocol to help with the design of polymer monolithic capillary columns.
Zhuoheng Zhou was trained as a chemist at Xiamen University (XMU) before he obtained his MSc degree in analytical chemistry at the Environmental Research Institute, National University of Singapore (NUS). He then enrolled in Vrije Universiteit Brussel (VUB) and joined the Bio-Analytical Separation Science (BASS) group as a PhD researcher under the supervision of Sebastiaan Eeltink and Gert Desmet. He is currently conducting his postdoctoral research, which focuses on UHPLC instrumentation and microcolumn technology, and their application in environmental analysis, biopharmaceutical characterization, and proteomic profiling.
SPE-Based Method for Detecting Harmful Textile Residues
January 14th 2025University of Valencia scientists recently developed a method using solid-phase extraction (SPE) followed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC–HRMS/MS) for detecting microplastics and other harmful substances in textiles.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.